Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
This trial is active, not recruiting.
|Conditions||tuberculosis, lung cancer|
|Sponsor||Taipei Medical University WanFang Hospital|
|Start date||July 2010|
|End date||June 2011|
|Trial size||40 participants|
|Trial identifier||NCT01322685, 99042|
The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.
|Observational model||case control|
Tuberculosis or lung cancer group
Male or female participants from 17 years up to 90 years old.
Inclusion Criteria: - Health group: between 17 to 90 years old - Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old Exclusion Criteria: - Women subjects are before or after the period within two days
|Official title||Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens|
|Principal investigator||Kuo-Sheng Hung|
Call for more information